← Open Payments lookup

UZOMA OSUCHUKWU: Open Payments

NPI 1063760411 · N LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$915 in 46 payments from 9 companies in 2025. Trend: 2023 $683 · 2024 $1,165 · 2025 $915

Food & beverage: $915
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$226
E.R. Squibb & Sons, L.L.C.9$211
Alkermes, Inc.6$158
Otsuka America Pharmaceutical, Inc.7$151
Janssen Pharmaceuticals, Inc2$46
Lundbeck LLC3$46
Neurocrine BioSciences, Inc.2$35
Bausch Health US, LLC1$25
ABBVIE INC.1$16

Products named: CAPLYTA, COBENFY, ARISTADA, REXULTI, INVEGA SUSTENNA, ABILIFY ASIMTUFII, INGREZZA, APLENZIN.

Industry payments across NV — which companies pay providers there.